Related Experiment Videos
Inflammatory, atherothrombotic aspects of type 2 diabetes
1Academic Unit of Molecular Vascular Medicine, The Leeds Institute of Genetics Health and Therapeutics Laboratories, Faculty of Medicine and Health, University of Leeds, UK. p.j.grant@leeds.ac.uk
Insights
Diabetes accelerates cardiovascular disease through inflammation and thrombosis. This review examines the link between type 2 diabetes, inflammation, and atherothrombotic processes contributing to vascular disease.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Pathology
Background:
- Diabetes mellitus and cardiovascular disease (CVD) exhibit a strong comorbidity.
- Vascular disease development involves complex metabolic, inflammatory, and coagulation pathways.
- Insulin resistance is linked to hypertension, hyperglycemia, dyslipidemia, inflammation, and thrombosis.
Purpose of the Study:
- To review the inflammatory and atherothrombotic aspects of type 2 diabetes.
- To explore mechanisms contributing to accelerated vascular disease in diabetic populations.
Main Methods:
- Systematic review of MEDLINE-searched literature from 1990 to 2005.
- Focus on inflammatory and atherothrombotic factors in type 2 diabetes.
Main Results:
- Diabetic patients show increased inflammatory cells and thrombosis in coronary plaques.
- C-reactive protein levels predict incident diabetes and CVD.
- Inflammation and coagulation are co-regulated processes implicated in vascular complications.
Conclusions:
- Inflammatory and thrombotic processes are key contributors to accelerated vascular disease in type 2 diabetes.
- Understanding these mechanisms is crucial for managing cardiovascular risk in diabetic patients.
Background:
There is a tight association between diabetes and cardiovascular disease - both occur more commonly together than independently. The development of vascular disease is dependent upon complex interactions between a number of metabolic pathways involving both fluid phase proteins and cellular components. Inflammation and coagulation are two intimately linked processes that are co-regulated. The characteristic cluster of risk factors - hypertension, hyperinsulinaemia, hyperglycaemia and lipid abnormalities, which are associated with insulin resistance - have been expanded to include inflammation and thrombotic risk. Studies in patients with diabetes indicate a higher prevalence of both inflammatory cells and thrombosis in coronary plaques in comparison to non-diabetic subjects and measures of C-reactive protein predict the development of both diabetes and cardio vascular disease in prospective studies.
Scope:
This review (based on MEDLINE searches, 1990 to 2005) looks at the inflammatory, atherothrombotic aspects of type 2 diabetes that may be involved in the accelerated development of vascular disease in the population with diabetes.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease I: Introduction